Security key
451033708
iBio, Inc. - Common Stock, par value $0.001 per share (IBIO)
CUSIP: 451033708
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 2,607,512
- Total 13F value
- $5,788,674
- Share change
- +156,394
- SEC-reported price per share
- $2.22
- Number of holders
- 31
- Value change
- +$356,141
- Number of buys
- 6
- Number of sells
- 5
- Shares outstanding
- 64,277,140
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
31
Top holders
10
IBIO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
iBio, Inc. SEC filings
iBio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 451033708
Recent filing periods:
Ownership snapshot
Top reported holders of IBIO - iBio, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ikarian Capital, LLC
Disclosed value leader
Ikarian Capital, LLC
Comparable rows
0/15
Latest evidence
30 Jun 2024
13F
3/4/5
Highest disclosed value: $1,266,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Ikarian Capital, LLC has the largest disclosed position value at $1.27M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ikarian Capital, LLC's linked filing trail.
Disclosed position value
Top 5
Ikarian Capital, LLC
$1.27M
Lynx1 Capital Management LP
$1.27M
ADAR1 Capital Management, LLC
$1.2M
Opaleye Management Inc.
$791.2K
BOOTHBAY FUND MANAGEMENT, LLC
$336.6K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ikarian Capital, LLC |
13F
Company
|
—
denominator unverified
|
$1,266,000
600,000 shares
|
— | 30 Jun 2024 |
| Lynx1 Capital Management LP |
13F
Company
|
—
denominator unverified
|
$1,266,000
600,000 shares
|
— | 30 Jun 2024 |
| ADAR1 Capital Management, LLC |
13F
Company
|
—
denominator unverified
|
$1,202,700
570,000 shares
|
— | 30 Jun 2024 |
| Opaleye Management Inc. |
13F
Company
|
—
denominator unverified
|
$791,250
375,000 shares
|
— | 30 Jun 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$336,619
159,535 shares
|
— | 30 Jun 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$103,805
49,197 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
31
Shares
2,607,512
Rows available
31
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2026 Across Filers
Q2 2026 holders
55
Q3 2024 holders
31
Holder diff
-24
| Investor | Q2 2026 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend